Although the GLO1 transgene did not protect Apoe−/− mice from accelerated atherosclerosis after STZ treatment, it appeared to reduce MG‐H1 immunoreactivity in aortic extracts from diabetic animals (Fig. 3E). The gene discussed is APOE; the disease is atherosclerosis.